GPT Activators
GPT activators, as proposed here, are chemicals that potentially enhance the enzymatic activity of UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase indirectly by modulating the cellular environment or the glycosylation pathway. These chemicals do not activate GPT directly but influence pathways and conditions that could lead to increased efficiency or upregulation of the enzyme's activity.
Compounds like Tunicamycin and Thapsigargin, while primarily known as stressors to the endoplasmic reticulum, could in specific conditions lead to a compensatory upregulation of glycosylation processes, indirectly enhancing GPT activity. Similarly, chemical chaperones like 4-Phenylbutyrate aid in protein folding and stability, potentially creating a favorable environment for GPT's function. Furthermore, substrates and intermediates in glycosylation pathways, such as Glucosamine and Mannose, could indirectly boost GPT activity by increasing substrate availability or through feedback mechanisms that upregulate glycosylation enzymes. Inhibitors of glycosidase enzymes, including Castanospermine and Swainsonine, might indirectly stimulate GPT activity by triggering cellular responses to maintain glycosylation levels.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
While primarily an inhibitor of N-linked glycosylation, Tunicamycin in sub-inhibitory concentrations could potentially provide a stress condition that upregulates compensatory mechanisms, indirectly enhancing GPT activity. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
4-PBA acts as a chemical chaperone, potentially enhancing protein folding and stability, indirectly influencing the environment in which GPT operates. | ||||||
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $201.00 $779.00 | ||
Glucosamine is a substrate for glycosylation pathways and could potentially upregulate these pathways, indirectly enhancing GPT activity. | ||||||
D-Mannose | 3458-28-4 | sc-211180 sc-211180A | 100 g 250 g | $103.00 $161.00 | 1 | |
Mannose is involved in glycosylation pathways, and its supplementation could indirectly enhance GPT activity by increasing substrate availability. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Castanospermine, an inhibitor of glucosidase I and II, might lead to an adaptive response upregulating glycosylation pathways, potentially enhancing GPT activity indirectly. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Similar to Castanospermine, Deoxynojirimycin inhibits glucosidases and might trigger compensatory mechanisms in the glycosylation pathway, indirectly affecting GPT activity. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Swainsonine inhibits mannosidase II and could lead to indirect upregulation of glycosylation processes, potentially enhancing GPT activity. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $135.00 $540.00 $1025.00 $6248.00 | 25 | |
As an inhibitor of mannosidase I, Kifunensine might cause an indirect upregulation of glycosylation enzymes including GPT. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi structure but could lead to compensatory mechanisms in the ER affecting GPT activity indirectly. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin induces ER stress, potentially upregulating ER-related processes including N-linked glycosylation and indirectly GPT activity. | ||||||